Earnings Review
Coromandel Intl's Q2 consol PAT, sales surge YoY, beat view
This story was originally published at 16:27 IST on 30 October 2025
Register to read our real-time news.Informist, Thursday, Oct. 30, 2025
Please click here to read all liners published on this story
--Coromandel Intl Jul-Sept consol net profit INR 8.05 bln
--Analysts saw Coromandel Intl Jul-Sept consol net profit INR 7.52 bln
--Coromandel Intl Jul-Sept consol revenue INR 96.54 bln
--Analysts saw Coromandel Intl Jul-Sept consol revenue INR 86.54 bln
--Coromandel Intl Jul-Sept consol PAT INR 8.05 bln vs INR 6.64 bln year ago
--Coromandel Intl Jul-Sept consol revenue INR 96.54 bln vs INR 74.33 bln
--Coromandel Intl Apr-Sept consol PAT INR 13.10 bln vs INR 9.75 bln year ago
--Coromandel Intl Apr-Sept consol revenue INR 166.96 bln vs INR 121.62 bln
--Coromandel Intl board OKs granting inter-corporate loan to arm NACL Ind
By Udita S. Jaiswal
MUMBAI – Coromandel International Ltd. reported a healthy growth in its consolidated net profit for the September quarter as well as revenue, which also surpassed the Street's expectations. Even though the company's expenses increased in double digits from the year-ago quarter, the strong revenue growth across its business verticals, particularly its core nutrients and allied business, aided its financial performance.
Coromandel's consolidated net profit for the quarter was INR 8.05 billion, up over 21% on year. This rise is more than the INR 7.52 billion analysts had expected. The company's net sales grew nearly 30% on year to INR 96.54 billion, also higher than the near INR 87 billion sales anticipated by analysts. Sequentially, this means a 59% growth in the bottom line and 37% rise in the top line.
The company's core vertical, its nutrient and allied business, grew 28% on year to INR 86.61 billion. This segment accounted for 89% of Coromandel's overall revenue in the reporting quarter. The remaining 11% of the chemical entity's revenue came from its crop protection segment, which reported a 42% on-year growth in revenue to INR 10.69 billion.
The total income of the company rose over 30% on year to INR 97.71 billion. Total expenses rose faster than the top line, up 32% on year at INR 87.11 billion due to the significant rise in raw materials costs. The agrochemicals player's raw materials costs jumped nearly 40% on year to INR 47.17 billion in Jul-Sept.
For the six months ended September, the company's net profit rose 34% on year to INR 13.10 billion and net sales increased 37% to INR 166.69 billion. Total expenses during the period increased 39% to INR 151.60 billion.
The board gave its approval to grant an inter-corporate loan of INR 1.60 billion to its listed subsidiary NACL Industries Ltd. It also approved issuing a letter of comfort of up to INR 5.50 billion in favour of the subsidiary's lenders. This will enable NACL Industries to secure loans from banks and financial institutions at more competitive interest rates, thereby contributing to improved business and financial performance, the parent company said in a filing.
Coromandel International released its quarterly results during market hours. On Thursday, its shares ended almost 4% lower at INR 2,174.20 on the National Stock Exchange. End
Edited by Tanima Banerjee
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2025. All rights reserved.
To read more please subscribe
